Albireo Pharma, Inc. (ALBO): Price and Financial Metrics

ALBO POWR Grades

• Growth is the dimension where ALBO ranks best; there it ranks ahead of 87.77% of US stocks.
• The strongest trend for ALBO is in Value, which has been heading up over the past 179 days.
• ALBO's current lowest rank is in the Quality metric (where it is better than 11.45% of US stocks).

ALBO Stock Summary

• For ALBO, its debt to operating expenses ratio is greater than that reported by merely 11.08% of US equities we're observing.
• With a price/sales ratio of 15.17, Albireo Pharma Inc has a higher such ratio than 90.62% of stocks in our set.
• Revenue growth over the past 12 months for Albireo Pharma Inc comes in at 388.43%, a number that bests 97.85% of the US stocks we're tracking.
• Stocks that are quantitatively similar to ALBO, based on their financial statements, market capitalization, and price volatility, are KMPH, EPZM, KPTI, INFN, and BYSI.
• ALBO's SEC filings can be seen here. And to visit Albireo Pharma Inc's official web site, go to www.albireopharma.com.

ALBO Valuation Summary

• ALBO's price/sales ratio is 63.7; this is 461.23% higher than that of the median Healthcare stock.
• Over the past 173 months, ALBO's price/sales ratio has gone NA NA.
• ALBO's price/sales ratio has moved NA NA over the prior 173 months.

Below are key valuation metrics over time for ALBO.

ALBO Growth Metrics

The 5 year net cashflow from operations growth rate now stands at -274.67%.
• The 4 year cash and equivalents growth rate now stands at 349.92%.
• The 5 year cash and equivalents growth rate now stands at 349.92%.

Over the past 70 months, ALBO's revenue has gone up $40,579,000.

The table below shows ALBO's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	40.579	-107.559	-34.03
2021-09-30	10.774	-121.863	-47.867
2021-06-30	9.241	-120.352	-135.696
2021-03-31	8.725	-111.949	-119.878
2020-12-31	8.308	-101.029	-107.633
2020-09-30	12.023	-85.234	-90.356

ALBO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ALBO has a Quality Grade of D, ranking ahead of 12.41% of graded US stocks.
• ALBO's asset turnover comes in at 0.035 -- ranking 346th of 680 Pharmaceutical Products stocks.
• LCI, MBIO, and XNCR are the stocks whose asset turnover ratios are most correlated with ALBO.

The table below shows ALBO's key quality metrics over time.